Voloridge Investment Management’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $21.4M | Sell |
338,804
-84,064
| -20% | -$5.31M | 0.08% | 304 |
|
2025
Q1 | $22.4M | Buy |
422,868
+42,331
| +11% | +$2.24M | 0.08% | 323 |
|
2024
Q4 | $21.3M | Buy |
380,537
+27,214
| +8% | +$1.52M | 0.08% | 336 |
|
2024
Q3 | $18.5M | Sell |
353,323
-108,865
| -24% | -$5.7M | 0.07% | 397 |
|
2024
Q2 | $19M | Sell |
462,188
-11,267
| -2% | -$463K | 0.07% | 384 |
|
2024
Q1 | $20.5M | Buy |
473,455
+110,738
| +31% | +$4.8M | 0.07% | 327 |
|
2023
Q4 | $16.7M | Buy |
362,717
+342,350
| +1,681% | +$15.7M | 0.07% | 362 |
|
2023
Q3 | $467K | Buy |
+20,367
| New | +$467K | ﹤0.01% | 1221 |
|
2023
Q2 | – | Sell |
-193,590
| Closed | -$3.45M | – | 1538 |
|
2023
Q1 | $3.45M | Sell |
193,590
-1,406
| -0.7% | -$25.1K | 0.02% | 798 |
|
2022
Q4 | $5.68M | Sell |
194,996
-48,412
| -20% | -$1.41M | 0.03% | 602 |
|
2022
Q3 | $5.96M | Buy |
+243,408
| New | +$5.96M | 0.03% | 591 |
|
2021
Q1 | – | Sell |
-7,175
| Closed | -$213K | – | 1623 |
|
2020
Q4 | $213K | Sell |
7,175
-29,794
| -81% | -$884K | ﹤0.01% | 1264 |
|
2020
Q3 | $801K | Buy |
+36,969
| New | +$801K | 0.01% | 1002 |
|